Zimmer Biomet director granted phantom stock units

HIGGINS ARTHUR J reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

HIGGINS ARTHUR J reported acquisition or exercise transactions in this Form 4 filing.

ZIMMER BIOMET HOLDINGS, INC. director Arthur J. Higgins received a grant of 317.369 Phantom Stock Units under the company’s Deferred Compensation Plan for Non-Employee Directors. Each unit is linked 1-for-1 to a share of common stock but will be settled in cash, not stock.

After this award, Higgins holds a total of 37,674.691 Phantom Stock Units on a direct basis. These units are scheduled to be paid out in cash in ten annual installments, beginning within sixty days after the end of the calendar year in which his service as a director ends.

Insider Trade Summary

Grant/Award: 317.369 shares

Grant/Award 1 txn

Insider HIGGINS ARTHUR J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	317.369	$0.00	$0.00

Holdings After Transaction: Phantom Stock Units — 37,674.691 contracts (Direct)

Footnotes (3)

1. F1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
2. F2. The Conversion or Exercise Price of Derivative Security is 1-for-1.
3. F3. Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Key Figures

Phantom Stock Units granted: 317.369 units Total Phantom Stock Units after grant: 37,674.691 units Transaction price per unit: $0.0000 per unit +2 more

5 metrics

Phantom Stock Units granted 317.369 units Award under Deferred Compensation Plan for Non-Employee Directors

Total Phantom Stock Units after grant 37,674.691 units Holdings following reported transaction

Transaction price per unit $0.0000 per unit Indicates compensation award, not purchase

Conversion ratio 1-for-1 to common stock Phantom Stock Units value linked to common shares

Payout schedule 10 annual installments Cash settlement after end of director’s service year

Key Terms

Phantom Stock Units, Deferred Compensation Plan for Non-Employee Directors, Conversion or Exercise Price, settled in cash, +1 more

5 terms

Phantom Stock Units financial

"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

Deferred Compensation Plan for Non-Employee Directors financial

"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."

Conversion or Exercise Price financial

"The Conversion or Exercise Price of Derivative Security is 1-for-1."

settled in cash financial

"Units are to be settled in cash in ten annual installments"

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

What did Zimmer Biomet (ZBH) director Arthur J. Higgins report on this Form 4?

Arthur J. Higgins reported receiving 317.369 Phantom Stock Units as a compensation award. These units are tied 1-for-1 to Zimmer Biomet common stock value but will be settled in cash according to the company’s non-employee director deferred compensation plan.

How many Phantom Stock Units does Arthur J. Higgins now hold at Zimmer Biomet (ZBH)?

Following this grant, Arthur J. Higgins holds 37,674.691 Phantom Stock Units directly. This total includes the newly awarded 317.369 units and represents his accumulated deferred compensation under Zimmer Biomet’s plan for non-employee directors.

How are Zimmer Biomet (ZBH) Phantom Stock Units for directors settled?

Zimmer Biomet Phantom Stock Units for non-employee directors are settled in cash, not shares. Payments are made in ten annual installments, starting within sixty days after the end of the calendar year in which the director’s board service ends, following the plan’s terms.

What is the conversion rate of Zimmer Biomet (ZBH) Phantom Stock Units to common stock?

Each Zimmer Biomet Phantom Stock Unit is linked to common stock on a 1-for-1 basis. This means the unit’s value mirrors one share of common stock, although the units themselves are ultimately paid in cash rather than delivered as actual stock.

Does Arthur J. Higgins pay anything for the Zimmer Biomet (ZBH) Phantom Stock Units granted?

The reported transaction price per Phantom Stock Unit is $0.0000, indicating Higgins did not pay cash to receive this award. It reflects a compensation grant under Zimmer Biomet’s Deferred Compensation Plan for Non-Employee Directors, not an open-market purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HIGGINS ARTHUR J

(Last) (First) (Middle)

345 E. MAIN STREET

(Street)

WARSAW INDIANA 46580

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units(1)	$86.65(2)	06/30/2026		A		317.369		(3)	(3)	Common Stock	317.369	$0	37,674.691	D

Explanation of Responses:

1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

2. The Conversion or Exercise Price of Derivative Security is 1-for-1.

3. Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

	/s/ Matthew R. St. Louis, Attorney-in-Fact for Arthur J. Higgins (power of attorney previously filed)	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)